
The Medicines & Healthcare products Regulatory Agency (MHRA) held a public consultation from May 20 to June 14, 2024, on their proposed amendments to the Medical Devices Regulations 2002 (MDR 2002) regarding the Common Specifications (CS) requirements for certain high-risk in vitro diagnostic (IVD) devices, including COVID-19 tests. In this blog, we discuss the outcome of the consultation and th..